XmAb23104

Xencor begins phase 1 trial of XmAb23104 in advanced solid tumors
Pharmaceutical Business Review
Fri, 05/10/19 - 10:46 am
Xencor
solid tumors
bispecific antibodies
clinical trials
XmAb23104